About Our Team

We represent patients who have been injured by the negligence of others, where by a health care provider who violated a patient safety rule, or by a corporation that failed to warn about dangerous side effects of its pharmaceutical products.

With more than 50 years of combined legal experience, we have represents patients and their families in hundreds of jury trials, bench trials, and mediations, in both state and federal court, to bring justice on behalf of deserving individuals who have been catastrophically injured. We take each case personally and give it our full attention to ensure that our client’s legal rights are protected and wrongdoers are held accountable, in order to improve public safety for all.

Ozempic Lawsuits

History, Ozempic has been commonly used for treating diabetes. More recently, there has been a rush to prescribe and use Ozempic and other similar medications for weight loss. Patients have reportedly experienced horrible, debilitating side effects, which they allege were not properly disclosed. As of March 2024, there are several lawsuits underway related to Ozempic’s side effects, particularly focusing on severe gastrointestinal issues such as gastroparesis, ileus, and intestinal blockage. These lawsuits allege that the drug’s manufacturer, Novo Nordisk, failed to adequately warn patients and healthcare providers about these risks.

A significant development in this litigation is the consolidation of lawsuits into a federal multidistrict litigation (MDL). This consolidation aims to streamline the legal process and manage the lawsuits more efficiently. The plaintiffs argue that they suffered from severe gastrointestinal problems after taking Ozempic, including symptoms like nausea, vomiting, abdominal bloating, and severe dehydration, among others. Some of the lawsuits mention that the drug was prescribed for weight loss, which adds another layer to the legal proceedings considering the implications of off-label use.

The number of lawsuits could potentially grow significantly, with some attorneys suggesting that the total might reach up to 10,000 cases. This situation is reminiscent of other pharmaceutical litigation where the number of claimants expanded greatly as more people became aware of the litigation. It’s also worth noting that while the primary focus of these lawsuits is on Ozempic, other similar drugs in the GLP-1 receptor agonist class, such as Mounjaro (tirzepatide) by Eli Lilly, are also mentioned in relation to similar side effects. The litigation raises important questions about drug safety, the adequacy of warnings provided to patients and healthcare providers, and the responsibilities of pharmaceutical companies.

Contact Us

Given the complexity and potential scale of this litigation, our team is ready for the fight. If you have been injured as a result of catastrophic side effects from Ozempic or other weight-loss medication, contact us to sign-up today.